Alzheimer's & Dementia·15 SepAlzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologiesReviewIndustry & policyPaper
AAIC 2025 Abstract·26 DecDiagnostic performance of plasma biomarkers for detecting amyloid co‐pathology in Neuronal α‐Synuclein DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecGABriella, a Phase 2a study investigating the gamma‐secretase modulator RG6289 in individuals at risk for and at the prodromal stage of Alzheimer’s disease: baseline characteristics of the recruited participantsTrial in peoplePopulationsPaper